Optimal two-stage designs for phase II clinical trials

Simon, 1987, Design, Analysis and Reporting of Cancer Clinical Trials

Colton, 1976, Two-stage plans compared with fixed-sample-size and Wald SPRT plans, J Am Stat Assoc, 71, 80, 10.2307/2285735

McPherson, 1982, On choosing the number of interim analyses in clinical trials, Stat Med, 1, 25, 10.1002/sim.4780010105

Jennison, 1987, Efficient group sequential tests with unpredictable group sizes, Biometrika, 74, 155, 10.1093/biomet/74.1.155

Gehan, 1961, The determination of the number of patients required in a follow-up trial of a new chemotherapeutic agent, J Chron Dis, 13, 346, 10.1016/0021-9681(61)90060-1

Jennison, 1983, Confidence interbals for a binomial parameter following a multistage test with application to MIL-STD 105D and medical trials, Technometrics, 25, 49, 10.2307/1267726

Chang, 1986, Confidence intervals following group sequential tests, Controlled Clin Trials, 7, 18, 10.1016/0197-2456(86)90004-8

Schultz, 1973, Multi-stage procedures for drug screening, Biometrics, 29, 293, 10.2307/2529393

Fleming, 1982, One sample multiple testing procedure for phase II clinical trials, Biometrics, 38, 143, 10.2307/2530297

O'Brien, 1979, A multiple testing procedure for clinical trials, Biometrics, 35, 549, 10.2307/2530245

Lee, 1979, Two stage plans for patient accrual in phase II cancer clinical trials, Cancer Treat Rep, 63, 1721

Herson, 1979, Predictive probability early termination plans for phase II clinical trials, Biometrics, 35, 775, 10.2307/2530109

Sylvester, 1977, Design of phase II trials in clinical trials in cancer using decision theory, Cancer Treat Rep, 64, 519

Chang, 1987, Designs for group sequential phase II clinical trials, Biometrics, 43, 865, 10.2307/2531540

DeMets, 1984, Stopping guidelines versus stopping rules: A practitioner's point of view, Communications Stat Theory Meth, 13, 2395, 10.1080/03610928408828833